It is not the quantity but the quality of LDL that contributes to disease.
Findings highlight promising targets for lung fibrosis treatments
A more thorough and specific understanding of how glycosylation affects disease may provide novel targets in diseases that currently lack effective treatment options.
They hope to identify new targets for developing drugs to treat or slow processes leading to Alzheimer’s disease.
Focused on research and development of vaccines, treatment and detection of bacterial infections that cause meningitis, gonorrhea and septicemia.
The assistant professor of medicine received a three-year, $200,000 Walter and Marie Coyle Award from the National Scleroderma Foundation and an AHA Career Development Award for $231,000.
Her research focuses on human genetics and Alzheimer’s disease risk.
This is the foundation’s third grant, bringing their total support since 2020 to more than $400,000.
TMIGD1 can be pharmacologically targeted to prevent kidney damage.
Study details more than 60 cases of CTE diagnosed in athletes under age 30, including first American woman soccer player diagnosed with CTE.